All articles by Divya Tirumalaraju

  1. Novavax receives $1.6bn from US Government for Covid-19 vaccine

    Novavax has received $1.6bn under the US Government’s Operation Warp Speed (OWS) programme to support the development and manufacturing of…
    Read More…

    7 Jul
  2. Novavax receives $1.6bn from US Government for Covid-19 vaccine

    Novavax has received $1.6bn under the US Government’s Operation Warp Speed (OWS) programme to support the development and manufacturing of…
    Read More…

    7 Jul
  3. Mylan gets approval for emergency use of remdesivir for Covid-19

    Mylan has secured regulatory approval from the Drug Controller General of India (DCGI) for restricted emergency use of 100mg/vial remdesivir…
    Read More…

    7 Jul
  4. CureVac secures European funding for infectious disease vaccines

    The European Investment Bank (EIB) and European Commission have agreed to provide German company CureVac with a €75m funding for…
    Read More…

    7 Jul
  5. Emergent to produce drug substance for J&Js Covid-19 vaccine

    Emergent BioSolutions has entered a five-year agreement with Johnson & Johnson unit Janssen Pharmaceutical for large-scale manufacturing of drug substance…
    Read More…

    6 Jul
  6. Medivir and SciLifeLab partner to identify Covid-19 drug candidates

    Swedish drug development company Medivir has partnered with SciLifeLab, a life science research firm, to identify compounds with the potential…
    Read More…

    6 Jul
  7. Gilead gets EC conditional approval for remdesivir to treat Covid-19

    The European Commission (EC) has provided conditional marketing authorisation for Gilead Sciences to use Veklury (remdesivir) for the treatment of…
    Read More…

    6 Jul
  8. KKR to buy controlling stake in J.B. Chemicals & Pharmaceuticals

    Investment firm KKR has signed a definitive agreement to acquire a controlling stake in India-based J.B. Chemicals & Pharmaceuticals, which…
    Read More…

    3 Jul
  9. Russia’s RDIF, ChemRar to boost production of Avifavir for Covid-19

    A joint venture established by the Russian Direct Investment Fund (RDIF) and ChemRar Group is set to boost production of…
    Read More…

    3 Jul
  10. ViiV Healthcare gets FDA approval for HIV therapy Rukobia

    ViiV Healthcare has received the US Food and Drug Administration (FDA) approval for Rukobia (fostemsavir) to treat human immunodeficiency virus…
    Read More…

    3 Jul
Close
Close
Close

Go Top